 | • レポートコード：QYR2104Z5950 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、内臓痛のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛剤、疼痛修飾剤）、用途別市場規模（間質性膀胱炎、クローン病、過敏性腸症候群、慢性前立腺炎）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・内臓痛の市場動向 ・企業の競争状況、市場シェア ・内臓痛の種類別市場規模（鎮痛剤、疼痛修飾剤） ・内臓痛の用途別市場規模（間質性膀胱炎、クローン病、過敏性腸症候群、慢性前立腺炎） ・内臓痛の北米市場規模2016-2027（アメリカ、カナダ） ・内臓痛のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・内臓痛のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・内臓痛の中南米市場規模2016-2027（メキシコ、ブラジル） ・内臓痛の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Johnson & Johnson、Abbvie、Takeda、Allergan、AstraZeneca） ・結論 |
Visceral pain is pain that results from the activation of nociceptors of the thoracic, pelvic, or abdominal viscera (organs). Visceral structures are highly sensitive to distension (stretch), ischemia and inflammation, but relatively insensitive to other stimuli that normally evoke pain such as cutting or burning. Visceral pain is diffuse, difficult to localize and often referred to a distant, usually superficial, structure. It may be accompanied by symptoms such as nausea, vomiting, changes in vital signs as well as emotional manifestations. The pain may be described as sickening, deep, squeezing, and dull. Distinct structural lesions or biochemical abnormalities explain this type of pain in only a proportion of patients. These diseases are grouped under gastrointestinal neuromuscular diseases (GINMD). Others can experience visceral pains, often very intense in nature, without any evidence of structural, biochemical or histolopathologic reason for such symptoms. These diseases are grouped under functional gastrointestinal disorders (FGID) and the pathophysiology and treatment can vary greatly from GINMD. The two major single entities among functional disorders of the gut are functional dyspepsia and irritable bowel syndrome.
Growing focus on research and development by pharmaceutical companies and government initiatives are expected to boost the visceral pain industry over the forecast period. The market is projected to witness significant gain during the forecast period owing to increasing collaboration within pharmaceutical companies. Moreover, growth in the interest of scientists and researchers in studying the pain originating from internal organs has mirrored in the consciousness of the importance of visceral pain in patients. Asia Pacific is expected to grow at the highest CAGR of 6.2% from 2017 to 2024. North America has been leading the market for visceral pain, it is expected that African countries will witness exponential growth during the forecast period.
Market Analysis and Insights: Global Visceral Pain Market
The global Visceral Pain market size is projected to reach US$ 1268.4 million by 2026, from US$ 979.4 million in 2019, at a CAGR of 3.7% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Visceral Pain market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Visceral Pain market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Visceral Pain market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Visceral Pain market.
Global Visceral Pain Scope and Market Size
Visceral Pain market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Visceral Pain market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Analgesics
Pain Modifiers
Segment by Application
Interstitial Cystitis
Crohn’s
Irritable Bowel
Chronic Prostatitis
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Johnson & Johnson
Abbvie
Takeda
Allergan
AstraZeneca
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Visceral Pain Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Analgesics
1.2.3 Pain Modifiers
1.3 Market by Application
1.3.1 Global Visceral Pain Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Interstitial Cystitis
1.3.3 Crohn’s
1.3.4 Irritable Bowel
1.3.5 Chronic Prostatitis
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Visceral Pain Market Perspective (2016-2027)
2.2 Visceral Pain Growth Trends by Regions
2.2.1 Visceral Pain Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Visceral Pain Historic Market Share by Regions (2016-2021)
2.2.3 Visceral Pain Forecasted Market Size by Regions (2022-2027)
2.3 Visceral Pain Industry Dynamic
2.3.1 Visceral Pain Market Trends
2.3.2 Visceral Pain Market Drivers
2.3.3 Visceral Pain Market Challenges
2.3.4 Visceral Pain Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Visceral Pain Players by Revenue
3.1.1 Global Top Visceral Pain Players by Revenue (2016-2021)
3.1.2 Global Visceral Pain Revenue Market Share by Players (2016-2021)
3.2 Global Visceral Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Visceral Pain Revenue
3.4 Global Visceral Pain Market Concentration Ratio
3.4.1 Global Visceral Pain Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Visceral Pain Revenue in 2020
3.5 Visceral Pain Key Players Head office and Area Served
3.6 Key Players Visceral Pain Product Solution and Service
3.7 Date of Enter into Visceral Pain Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Visceral Pain Breakdown Data by Type
4.1 Global Visceral Pain Historic Market Size by Type (2016-2021)
4.2 Global Visceral Pain Forecasted Market Size by Type (2022-2027)
5 Visceral Pain Breakdown Data by Application
5.1 Global Visceral Pain Historic Market Size by Application (2016-2021)
5.2 Global Visceral Pain Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Visceral Pain Market Size (2016-2027)
6.2 North America Visceral Pain Market Size by Type
6.2.1 North America Visceral Pain Market Size by Type (2016-2021)
6.2.2 North America Visceral Pain Market Size by Type (2022-2027)
6.2.3 North America Visceral Pain Market Size by Type (2016-2027)
6.3 North America Visceral Pain Market Size by Application
6.3.1 North America Visceral Pain Market Size by Application (2016-2021)
6.3.2 North America Visceral Pain Market Size by Application (2022-2027)
6.3.3 North America Visceral Pain Market Size by Application (2016-2027)
6.4 North America Visceral Pain Market Size by Country
6.4.1 North America Visceral Pain Market Size by Country (2016-2021)
6.4.2 North America Visceral Pain Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Visceral Pain Market Size (2016-2027)
7.2 Europe Visceral Pain Market Size by Type
7.2.1 Europe Visceral Pain Market Size by Type (2016-2021)
7.2.2 Europe Visceral Pain Market Size by Type (2022-2027)
7.2.3 Europe Visceral Pain Market Size by Type (2016-2027)
7.3 Europe Visceral Pain Market Size by Application
7.3.1 Europe Visceral Pain Market Size by Application (2016-2021)
7.3.2 Europe Visceral Pain Market Size by Application (2022-2027)
7.3.3 Europe Visceral Pain Market Size by Application (2016-2027)
7.4 Europe Visceral Pain Market Size by Country
7.4.1 Europe Visceral Pain Market Size by Country (2016-2021)
7.4.2 Europe Visceral Pain Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Visceral Pain Market Size (2016-2027)
8.2 Asia-Pacific Visceral Pain Market Size by Type
8.2.1 Asia-Pacific Visceral Pain Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Visceral Pain Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Visceral Pain Market Size by Type (2016-2027)
8.3 Asia-Pacific Visceral Pain Market Size by Application
8.3.1 Asia-Pacific Visceral Pain Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Visceral Pain Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Visceral Pain Market Size by Application (2016-2027)
8.4 Asia-Pacific Visceral Pain Market Size by Region
8.4.1 Asia-Pacific Visceral Pain Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Visceral Pain Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Visceral Pain Market Size (2016-2027)
9.2 Latin America Visceral Pain Market Size by Type
9.2.1 Latin America Visceral Pain Market Size by Type (2016-2021)
9.2.2 Latin America Visceral Pain Market Size by Type (2022-2027)
9.2.3 Latin America Visceral Pain Market Size by Type (2016-2027)
9.3 Latin America Visceral Pain Market Size by Application
9.3.1 Latin America Visceral Pain Market Size by Application (2016-2021)
9.3.2 Latin America Visceral Pain Market Size by Application (2022-2027)
9.3.3 Latin America Visceral Pain Market Size by Application (2016-2027)
9.4 Latin America Visceral Pain Market Size by Country
9.4.1 Latin America Visceral Pain Market Size by Country (2016-2021)
9.4.2 Latin America Visceral Pain Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Visceral Pain Market Size (2016-2027)
10.2 Middle East & Africa Visceral Pain Market Size by Type
10.2.1 Middle East & Africa Visceral Pain Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Visceral Pain Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Visceral Pain Market Size by Type (2016-2027)
10.3 Middle East & Africa Visceral Pain Market Size by Application
10.3.1 Middle East & Africa Visceral Pain Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Visceral Pain Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Visceral Pain Market Size by Application (2016-2027)
10.4 Middle East & Africa Visceral Pain Market Size by Country
10.4.1 Middle East & Africa Visceral Pain Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Visceral Pain Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Visceral Pain Introduction
11.1.4 Pfizer Revenue in Visceral Pain Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Visceral Pain Introduction
11.2.4 Johnson & Johnson Revenue in Visceral Pain Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Abbvie
11.3.1 Abbvie Company Details
11.3.2 Abbvie Business Overview
11.3.3 Abbvie Visceral Pain Introduction
11.3.4 Abbvie Revenue in Visceral Pain Business (2016-2021)
11.3.5 Abbvie Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Visceral Pain Introduction
11.4.4 Takeda Revenue in Visceral Pain Business (2016-2021)
11.4.5 Takeda Recent Development
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Visceral Pain Introduction
11.5.4 Allergan Revenue in Visceral Pain Business (2016-2021)
11.5.5 Allergan Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Visceral Pain Introduction
11.6.4 AstraZeneca Revenue in Visceral Pain Business (2016-2021)
11.6.5 AstraZeneca Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Visceral Pain Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Analgesics
Table 3. Key Players of Pain Modifiers
Table 4. Global Visceral Pain Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Visceral Pain Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Visceral Pain Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Visceral Pain Market Share by Regions (2016-2021)
Table 8. Global Visceral Pain Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Visceral Pain Market Share by Regions (2022-2027)
Table 10. Visceral Pain Market Trends
Table 11. Visceral Pain Market Drivers
Table 12. Visceral Pain Market Challenges
Table 13. Visceral Pain Market Restraints
Table 14. Global Visceral Pain Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Visceral Pain Market Share by Players (2016-2021)
Table 16. Global Top Visceral Pain Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Visceral Pain as of 2020)
Table 17. Ranking of Global Top Visceral Pain Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Visceral Pain Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Visceral Pain Product Solution and Service
Table 21. Date of Enter into Visceral Pain Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Visceral Pain Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Visceral Pain Revenue Market Share by Type (2016-2021)
Table 25. Global Visceral Pain Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Visceral Pain Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Visceral Pain Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Visceral Pain Revenue Market Share by Application (2016-2021)
Table 29. Global Visceral Pain Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Visceral Pain Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Visceral Pain Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Visceral Pain Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Visceral Pain Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Visceral Pain Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Visceral Pain Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Visceral Pain Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Visceral Pain Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Visceral Pain Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Visceral Pain Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Visceral Pain Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Visceral Pain Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Visceral Pain Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Visceral Pain Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Visceral Pain Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Visceral Pain Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Visceral Pain Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Visceral Pain Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Visceral Pain Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Visceral Pain Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Visceral Pain Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Visceral Pain Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Visceral Pain Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Visceral Pain Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Visceral Pain Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Visceral Pain Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Visceral Pain Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Visceral Pain Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Visceral Pain Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Visceral Pain Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Visceral Pain Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Visceral Pain Product
Table 64. Pfizer Revenue in Visceral Pain Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Johnson & Johnson Company Details
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Visceral Pain Product
Table 69. Johnson & Johnson Revenue in Visceral Pain Business (2016-2021) & (US$ Million)
Table 70. Johnson & Johnson Recent Development
Table 71. Abbvie Company Details
Table 72. Abbvie Business Overview
Table 73. Abbvie Visceral Pain Product
Table 74. Abbvie Revenue in Visceral Pain Business (2016-2021) & (US$ Million)
Table 75. Abbvie Recent Development
Table 76. Takeda Company Details
Table 77. Takeda Business Overview
Table 78. Takeda Visceral Pain Product
Table 79. Takeda Revenue in Visceral Pain Business (2016-2021) & (US$ Million)
Table 80. Takeda Recent Development
Table 81. Allergan Company Details
Table 82. Allergan Business Overview
Table 83. Allergan Visceral Pain Product
Table 84. Allergan Revenue in Visceral Pain Business (2016-2021) & (US$ Million)
Table 85. Allergan Recent Development
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Visceral Pain Product
Table 89. AstraZeneca Revenue in Visceral Pain Business (2016-2021) & (US$ Million)
Table 90. AstraZeneca Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Visceral Pain Market Share by Type: 2020 VS 2027
Figure 2. Analgesics Features
Figure 3. Pain Modifiers Features
Figure 4. Global Visceral Pain Market Share by Application: 2020 VS 2027
Figure 5. Interstitial Cystitis Case Studies
Figure 6. Crohn’s Case Studies
Figure 7. Irritable Bowel Case Studies
Figure 8. Chronic Prostatitis Case Studies
Figure 9. Visceral Pain Report Years Considered
Figure 10. Global Visceral Pain Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Visceral Pain Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Visceral Pain Market Share by Regions: 2020 VS 2027
Figure 13. Global Visceral Pain Market Share by Regions (2022-2027)
Figure 14. Global Visceral Pain Market Share by Players in 2020
Figure 15. Global Top Visceral Pain Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Visceral Pain as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Visceral Pain Revenue in 2020
Figure 17. Global Visceral Pain Revenue Market Share by Type (2016-2021)
Figure 18. Global Visceral Pain Revenue Market Share by Type (2022-2027)
Figure 19. North America Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Visceral Pain Market Share by Type (2016-2027)
Figure 21. North America Visceral Pain Market Share by Application (2016-2027)
Figure 22. North America Visceral Pain Market Share by Country (2016-2027)
Figure 23. United States Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Visceral Pain Market Share by Type (2016-2027)
Figure 27. Europe Visceral Pain Market Share by Application (2016-2027)
Figure 28. Europe Visceral Pain Market Share by Country (2016-2027)
Figure 29. Germany Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Visceral Pain Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Visceral Pain Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Visceral Pain Market Share by Region (2016-2027)
Figure 39. China Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Visceral Pain Market Share by Type (2016-2027)
Figure 47. Latin America Visceral Pain Market Share by Application (2016-2027)
Figure 48. Latin America Visceral Pain Market Share by Country (2016-2027)
Figure 49. Mexico Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Visceral Pain Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Visceral Pain Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Visceral Pain Market Share by Country (2016-2027)
Figure 55. Turkey Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Visceral Pain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Visceral Pain Business (2016-2021)
Figure 59. Johnson & Johnson Revenue Growth Rate in Visceral Pain Business (2016-2021)
Figure 60. Abbvie Revenue Growth Rate in Visceral Pain Business (2016-2021)
Figure 61. Takeda Revenue Growth Rate in Visceral Pain Business (2016-2021)
Figure 62. Allergan Revenue Growth Rate in Visceral Pain Business (2016-2021)
Figure 63. AstraZeneca Revenue Growth Rate in Visceral Pain Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
世界の内臓痛治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Visceral Pain Treatment Market The global Visceral Pain Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…- 世界の慢性膵炎疼痛市場規模・現状・予測（2021年-2027年） Chronic pancreatitis is a long term inflammation of pancreas which leads to permanent damage and digestion capability of pancreas. Most common symptoms include severe abdominal pain, diabetes, weight loss, producing greasy and foul-smelling stools etc. Common cause associated with chronic pancreatit…
- 世界の慢性腰痛治療市場規模・現状・予測（2021年-2027年） Low back pain can be standardized into two categories, acute and chronic. Pain for less than three months can be classified as acute, while continued pain for more than three months is classified as chronic. Market Analysis and Insights: Global Chronic Low Back Pain Treatment Market The global Chron…
- 世界の膝痛管理市場規模・現状・予測（2021年-2027年） Knee pain is a common pain associated with the bone structure of knee. Knee pain is often associated with age. Knee pain includes: limping due to discomfort, difficulty walking, climbing stairs, locking of knee, redness, swelling and inability to extend knee. The increasing cases of arthritis due to…
- 世界の市販鎮痛薬市場規模・現状・予測（2021年-2027年） Over-the-counter pain medication are very helpful for the person suffering from minor and major pain. As the over-the-counter are easily available without proper prescriptions and very effective to control the pain. Over-the-counter pain medication are approved product from the regulatory authority,…